ARTICLE | Company News
Weill Cornell Medical College, Annapurna Therapeutics deal
January 11, 2016 8:00 AM UTC
Weill granted Annapurna an exclusive license to three preclinical gene therapy programs for alpha-1 antitrypsin deficiency (AATD), hereditary angioedema (HAE) and severe allergies. Annapurna expects t...